CH Biotech R&D Co., Ltd.(TW:6534)
NT$86.00+0.50 (+0.58%)
TW:6534
CH Biotech R&D Co., Ltd. Revenue
NT$86.00
At close:+0.50 (+0.58%)
CH Biotech R&D Co., Ltd. (6534) Revenue
CH Biotech R&D Co., Ltd. Revenue
CH Biotech R&D Co., Ltd. had a revenue of 459.43M in the quarter ending Jun 30, 2026, with -47.16%. This bring the company's revenue in the last twelve months to 1.87B, Increased 2.12%. In the fiscal year ending Dec 31, 2025, CH Biotech R&D Co., Ltd. had annual revenue of 1.82B with 11.21% growth.
- Revenue (ttm)
- 1.87B
- Revenue Growth
- 6.31%
- P/S Ratio
- 4.59
- Revenue/Employee
- TWD 9,095,915
- Employees
- 200
- Market Cap
- TWD 8.35B
Revenue Chart
CH Biotech R&D Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.82B | 183.45M | 11.21% |
| Dec 31, 2024 | 1.64B | 120.91M | 7.98% |
| Dec 31, 2023 | 1.51B | 80.71M | 5.63% |
| Dec 31, 2022 | 1.43B | 415.61M | 40.81% |
| Dec 31, 2021 | 1.02B | 316.32M | 45.05% |
| Dec 31, 2020 | 702.19M | -138.49M | -16.47% |
| Dec 31, 2019 | 840.68M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.